Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 1, 2011, Pages 24-31

  Houben, Rein M G J ^a   Crampin, A C ^a,b   Ndhlovu, R ^b   Sonnenberg, P ^c   Godfrey Faussett, P ^a   Haas, W H ^d   Engelmann, G ^e   Lombard, C J ^f   Wilkinson, D ^g   Bruchfeld, J ^h   Lockman, S ^i,j,k   Tappero, J ^k   Glynn, J R ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KARONGA PREVENTION STUDY   (Malawi)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d ROBERT KOCH INSTITUTE   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^j BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^k CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

more..

Author keywords

HIV; Molecular epidemiology; Pooled data analysis; Systematic review; Tuberculosis

Indexed keywords

ARTICLE; BACTERIUM CULTURE; CLUSTER ANALYSIS; ENDEMIC DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LATENT TUBERCULOSIS; META ANALYSIS; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TUBERCULOSIS;

ADOLESCENT; ADULT; AGE FACTORS; CLUSTER ANALYSIS; ENDEMIC DISEASES; FEMALE; HIV INFECTIONS; HUMANS; LATENT TUBERCULOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; TUBERCULOSIS; VIRUS ACTIVATION; YOUNG ADULT;

EID: 78650098443     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Slutkin G, Leowski J, Mann J. The effects of the AIDS epidemic on the tuberculosis problem and tuberculosis programmes. Bull Int Union Tuberc Lung Dis 1988; 63(2): 21-24.
2. Corbett E L, Marston B, Churchyard G J, De Cock K M. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet 2006; 367: 926-937.
3. Corbett E L, Watt C J, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009-1021.
4. Sutherland I, Svandova E, Radhakrishna S. The development of clinical tuberculosis following infection with tubercle bacilli. Tubercle 1982; 63: 255-268.
5. Girardi E, Raviglione M C, Antonucci G, Godfrey-Faussett P, Ippolito G. Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS 2000; 14(Suppl 3): S47-S56.
6. Vynnycky E, Fine P E. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 1997; 119: 183-201.
7. Selwyn P A, Hartel D, Lewis V A, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-550.
8. Sonnenberg P, Murray J, Glynn J R, Shearer S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001; 358: 1687-1693.
9. Crampin A C, Mwaungulu J N, Mwaungulu F D, et al. Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS 2010; 24: 417-426.
10. Cohn D L, O'Brien R J. The use of restriction fragment length polymorphism (RFLP) analysis for epidemiological studies of tuberculosis in developing countries. Int J Tuberc Lung Dis 1998; 2: 16-26.
11. Crampin A C, Glynn J R, Traore H, et al. Tuberculosis transmission attributable to close contacts and HIV status, Malawi. Emerg Infect Dis 2006; 12: 729-735.
12. Espinal M A, Perez E N, Baez J, et al. Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Lancet 2000; 355: 275-280.
13. Corbett E L, Bandason T, Cheung Y-B, et al. Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control. Int J Tuberc Lung Dis 2009; 13: 1231-1237.
14. Elliott A M, Luo N, Tembo G, et al. Impact of HIV on tuberculosis in Zambia: a cross sectional study. BMJ 1990; 301: 412-415.
15. Kenyon T A, Creek T, Laserson K, et al. Risk factors for transmission of Mycobacterium tuberculosis from HIV-infected tuberculosis patients, Botswana. Int J Tuberc Lung Dis 2002; 6: 843-850.
16. Carvalho A C, DeRiemer K, Nunes Z B, et al. Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients. Am J Respir Crit Care Med 2001; 164: 2166-2171.
17. Johnson J L, Vjecha M J, Okwera A, et al. Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration. Int J Tuberc Lung Dis 1998; 2: 397-404.
18. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. Guidelines for second generation HIV surveillance: the next decade. WHO/CDS/EDC/2000.05. Geneva, Switzerland: WHO, 2000.
19. Glynn J R, Bauer J, de Boer A S, et al.; European Concerted Action on Molecular Epidemiology and Control of Tuberculosis. Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis [Position paper]. Int J Tuberc Lung Dis 1999; 3: 1055-1060.
20. Nelson L J, Wells C D. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004; 8: 636-647.
21. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997; 35: 907-914.
22. van Soolingen D, de Haas P E, Hermans P W, Groenen P M, van Embden J D. Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis. J Clin Microbiol 1993; 31: 1987-1995.
23. Higgins J P, Green S, eds. Cochrane handbook for systematic reviews of interventions. Version 5.0.0 ed. Cochrane Collaboration, 2008. http://www.cochrane-handbook.org Accessed November 2010.
24. Houben R M G J, Glynn J R. A systematic review and meta-analysis of molecular epidemiological studies of tuberculosis: development of a new tool to aid interpretation. Trop Med Int Health 2009; 14: 892-909.
25. Bruchfeld J, Aderaye G, Palme I B, et al. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol 2002; 40: 1636-1643.
26. Glynn J R, Crampin A C, Yates M D, et al. The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in northern Malawi. J Infect Dis 2005; 192: 480-487.
27. Yang Z H, Mtoni I, Chonde M, et al. DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania. J Clin Microbiol 1995; 33: 1064-1069.
28. Godfrey-Faussett P, Sonnenberg P, Shearer S C, et al. Tuberculosis control and molecular epidemiology in a South African gold-mining community. Lancet 2000; 356: 1066-1071.
29. Haas W H, Engelmann G, Amthor B, et al. Transmission dynamics of tuberculosis in a high-incidence country: prospective analysis by PCR DNA fingerprinting. J Clin Microbiol 1999; 37: 3975-3979.
30. Wilkinson D, Pillay M, Crump J, Lombard C, Davies G R, Sturm A W. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural Africa. Trop Med Int Health 1997; 2: 747-753.
31. Lockman S, Sheppard J D, Mwasekaga M, et al. DNA fingerprinting of a national sample of Mycobacterium tuberculosis isolates, Botswana, 1995-1996. Int J Tuberc Lung Dis 2000; 4: 584-587.
32. Houben R M G J, Crampin A C, Mallard K, et al. HIV and the risk of tuberculosis due to recent transmission over 12 years in Karonga District, Malawi. Trans R Soc Trop Med Hyg 2009; 103: 1187-1189.
33. Borgdorff M W, van der Werf M J, de Haas P E, Kremer K, van Soolingen D. Tuberculosis elimination in the Netherlands. Emerg Infect Dis 2005; 11: 597-602.
34. Morgan D, Mahe C, Mayanja B, Okongo J M, Lubega R, Whitworth J A. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? AIDS 2002; 16: 597-603.
35. Van de Paal L. HIV progression in absence of ART in rural Uganda. In: Meeting of the UNAIDS Reference Group on Estimates, Modelling and Projection. Sintra, Portugal: UNAIDS, 2004.
36. Corbett E L, Churchyard G J, Clayton T C, et al. HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners. AIDS 2000; 14: 2759-2768.
37. Jahn A, Floyd S, Crampin A C, et al. Population-level effect of HIV an adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet 2008; 371: 1603-1611.
38. Small P M, Hopewell P C, Singh S P, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-1709.
39. World Health Organization. Three I's meeting. Intensified case finding (IC), isoniazid preventive therapy (IPT) and TB infection control (IC) for people living with HIV. Report of a joint WHO, HIV/AIDS and TB Department meeting, 2-4 April 2008. Geneva, Switzerland: WHO, 2008.